Kwame has a PhD in Molecular Toxicology from the University of Leicester. Following academic postdoctoral work, he moved to Paris site of Sanofi R&D for an EU-Marie Curie Post-Doctoral Fellowship in Biophysics. He was subsequently employed as a Research Scientist in Molecular Modelling and spent over fifteen years providing in-silico drug discovery support to multi-disciplinary, early phase research programs.

Kwame has an MBA from Oxford Brookes University and is joining SPEX after spending time at Inkef Capital, a leading European Venture Capital firm, where he was part of the Healthcare team.